시장보고서
상품코드
1457945

경장 영양제 시장 : 시장 규모, 점유율 분석, 산업 수요 예측(-2030년)

Enteral Feeding Formulas Market Size and Share Analysis by Product, Age Category, Flow Type, Application, End User - Global Industry Demand Forecast to 2030

발행일: | 리서치사: Prescient & Strategic Intelligence | 페이지 정보: 영문 240 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 경장 영양제(Enteral Feeding Formulas) 시장은 2023년에 57억 8,180만 달러였으며, 2024년부터 2030년에 걸쳐 9.7%의 CAGR로 성장할 것으로 예상되며, 2030년에는 109억 6,370만 달러에 달할 것으로 예측됩니다. 이 시장 성장은 노인 인구의 급증과 당뇨병, 암, 신경 질환, 소화기 질환 등 만성 질환의 급증에 기인하고 있습니다.

표준형 제제가 업계를 선도

2023년에는 표준형 제제가 35% 이상의 최대 점유율을 차지했습니다.

또한, 이 카테고리는 예측 기간 동안 우위를 유지할 것으로 추정됩니다.

이 동향의 주요 요인은 정상적인 제형이 어린이이든 성인이든 정상적인 소화 기능을 가진 사람들을 위해 정확하게 처방된다는 것입니다.

소아과 카테고리가 최대 시장 점유율을 차지

용도별로 보면, 2023년에는 소아과 카테고리가 업계 내에서 가장 큰 소득 점유율을 획득했습니다.

또한 예측 기간 동안 9.8%의 CAGR을 유지할 것으로 예측됩니다.

이 동향은 조산아 증가나 아이의 만성적인 상황의 발생이 많은 것에 뒷받침되고 있습니다.

병원 카테고리가 최대 매출 점유율을 차지

2023년에는 병원 카테고리가 업계 최대 점유율을 차지하고 전체의 60% 이상을 차지했습니다.

이 카테고리는 또한 예측 기간 동안 크게 성장할 것으로 예상됩니다.

주로 장기 요양이 필요한 환자를 대상으로 하는 병원에서 이러한 처방의 이용 급증이 이 발전의 주된 추진력이 되고 있습니다.

북미가 경장 영양제 시장을 독점

북미는 2030년에도 약 55%의 점유율로 시장을 선도할 것으로 예상됩니다. 이는 미국에서 이러한 제품에 대한 FDA 규칙이 표준화되고 호의적으로 운영되고 있기 때문입니다.

세계의 경장 영양제(Enteral Feeding Formulas) 시장을 분석했으며, 시장의 기본 구조/최신 상황/주요 촉진 및 억제 요인/전 세계 및 지역별 및 주요 국가 시장 규모 동향 전망(수량, 금액 기준, 2017-2030년)/제품별·연령층별·플로우 유형별·용도별·최종 사용자별 상세 동향/현재 시장 경쟁 구도/주요 기업 프로파일 등 정보를 전해드립니다.

목차

제1장 조사 범위

제2장 조사 방법

제3장 주요 요약

제4장 시장 지표

제5장 산업 전망

  • 시장 역학
    • 동향
    • 성장 촉진 요인
    • 억제 요인/과제
    • 성장 촉진 요인/억제 요인의 영향 분석
  • COVID-19의 영향
  • Porter's Five Forces 분석

제6장 시장

  • 개요
  • 시장 규모 : 제품별(2017-2030년)
  • 시장 매출 : 제품별(2017-2030년)
  • 시장 규모 : 연령층별(2017-2030년)
  • 시장 매출 : 연령층별(2017-2030년)
  • 시장 규모 : 플로우 유형별(2017-2030년)
  • 시장 매출 : 플로우 유형별(2017-2030년)
  • 시장 규모 : 용도별(2017-2030년)
  • 시장 매출 : 용도별(2017-2030년)
  • 시장 규모 : 최종 사용자별(2017-2030년)
  • 시장 매출 : 최종 사용자별(2017-2030년)
  • 시장 규모 : 지역별(2017-2030년)
  • 시장 매출 : 지역별(2017-2030년)

제7장 북미 시장

  • 개요
  • 시장 규모 : 제품별(2017-2030년)
  • 시장 매출 : 제품별(2017-2030년)
  • 시장 규모 : 연령층별(2017-2030년)
  • 시장 매출 : 연령층별(2017-2030년)
  • 시장 규모 : 플로우 유형별(2017-2030년)
  • 시장 매출 : 플로우 유형별(2017-2030년)
  • 시장 규모 : 용도별(2017-2030년)
  • 시장 매출 : 용도별(2017-2030년)
  • 시장 규모 : 최종 사용자별(2017-2030년)
  • 시장 매출 : 최종 사용자별(2017-2030년)
  • 시장 규모 : 국가별(2017-2030년)
  • 시장 매출 : 국가별(2017-2030년)

제8장 유럽 시장

제9장 아시아 태평양 시장

제10장 남미 시장

제11장 중동 및 아프리카(MEA) 시장

제12장 미국 시장

  • 개요
  • 시장 규모 : 제품별(2017-2030년)
  • 시장 매출 : 제품별(2017-2030년)
  • 시장 규모 : 연령층별(2017-2030년)
  • 시장 매출 : 연령층별(2017-2030년)
  • 시장 규모 : 플로우 유형별(2017-2030년)
  • 시장 매출 : 플로우 유형별(2017-2030년)
  • 시장 규모 : 용도별(2017-2030년)
  • 시장 매출 : 용도별(2017-2030년)
  • 시장 규모 : 최종 사용자별(2017-2030년)
  • 시장 매출 : 최종 사용자별(2017-2030년)

제13장 캐나다 시장

제14장 독일 시장

제15장 프랑스 시장

제16장 영국 시장

제17장 이탈리아 시장

제18장 스페인 시장

제19장 일본 시장

제20장 중국 시장

제21장 인도 시장

제22장 호주 시장

제23장 한국 시장

제24장 브라질 시장

제25장 멕시코 시장

제26장 사우디아라비아 시장

제27장 남아프리카 시장

제28장 아랍에미리트(UAE) 시장

제29장 경쟁 구도

  • 시장 진출기업 및 제공 제품 및 서비스 목록
  • 주요 기업의 경쟁 벤치마킹
  • 주요 기업의 제품 벤치마킹
  • 최근의 전략 전개 상황

제30장 기업 프로파일

  • Abbott Laboratories
  • Danone SA
  • Fresenius Kabi AG
  • Nestle SA
  • Victus Inc.
  • Primus Pharmaceuticals Inc.
  • Meiji Holdings Company Ltd.

제31장 부록

LYJ 24.04.18

The enteral feeding formulas market achieved a value of USD 5,781.8 million in 2023 and is projected to grow to USD 10,963.7 million by 2030, exhibiting a compound annual growth rate (CAGR) of 9.7% between 2024 and 2030. This growth of the market can be credited to the surge in the elderly populace and the surge in the occurrence of chronic diseases, like diabetes, cancer, neurological diseases, and gastrointestinal diseases.

Factors That Are Boosting Market Growth

Enteral feeding formulas are specially formulated with a specific nutrient content to provide matching for malnourished individuals or individuals who are at risk of malnutrition. They have the necessary substances like vitamins, protein, and calories that one takes to live daily.

The WHO states that nearly half of the fatalities of children under five are related to undernutrition. This startling figure is flagrant, notably in middle-income countries.

Furthermore, the rising count of early births worldwide is propelling the acceptance of enteral feeding formulas to fulfill the nutritious needs of newborns, which is projected to boost the industry over the years. Moreover, the growing count of road accidents and wounds is set to propel the development of this industry.

Globally, road traffic accidents result in the deaths of roughly 1.2 million people annually.

Additionally, individuals injured in these accidents require time to heal, during which they may experience challenges with mobility and chewing.

Due to these factors, enteral feeding formulas become essential for providing necessary nutrition to injured individuals who are unable to eat conventionally.

Standard Formulas Are Leading the Industry

In 2023, standard formulas held the largest share of, more than 35% within the enteral feeding formulas industry.

The category is also estimated to continue to the dominant throughout the projection period.

The major factor for this trend is that standard formulas are precisely formulated for people with normal digestion, whether children or adults.

Standard formulas are adaptable as they can fulfill dual drives: as enteral feeding solutions and as oral supplements.

The Largest Share in The Market Was Held by The Pediatrics Category

In 2023, the pediatrics category generated the largest income share within the industry.

During the projection period, its development is projected to continue at a CAGR of 9.8% between.

This trend is propelled by a growing count of preterm births and a high occurrence of chronic situations among children.

Hospitals Category Accounts for Largest Revenue Share

In 2023, the Hospitals category held the largest industry share, of more than 60% of the total.

This category is also projected to witness significant development during the projection period.

The surge in the utilization of these formulas in hospitals, mainly for patients needing long-term care, is a major propeller of this development.

North America Dominates Enteral Feeding Formulas Market

North America is expected to continue leading the market with a share of around 55% in 2030. This will be due to the standardized and favorable FDA rules for these products in the U.S.

The US FDA has allowed infant formula manufacturers to increase the supply of pediatric formula by giving them temporary permission for enforcement discretion.

Table of Contents

Chapter 1. Research Scope

  • 1.1. Research Objectives
  • 1.2. Market Definition
  • 1.3. Analysis Period
  • 1.4. Market Size Breakdown by Segments
    • 1.4.1. Market size breakdown, by product
    • 1.4.2. Market size breakdown, by age category
    • 1.4.3. Market size breakdown, by flow type
    • 1.4.4. Market size breakdown, by application
    • 1.4.5. Market size breakdown, by end user
    • 1.4.6. Market size breakdown, by region
    • 1.4.7. Market size breakdown, by country
  • 1.5. Market Data Reporting Unit
    • 1.5.1. Volume
    • 1.5.2. Value
  • 1.6. Key Stakeholders

Chapter 2. Research Methodology

  • 2.1. Secondary Research
    • 2.1.1. Paid
    • 2.1.2. Unpaid
    • 2.1.3. P&S Intelligence database
  • 2.2. Primary Research
  • 2.3. Market Size Estimation
  • 2.4. Data Triangulation
  • 2.5. Currency Conversion Rates
  • 2.6. Assumptions for the Study
  • 2.7. Notes and Caveats

Chapter 3. Executive Summary

Chapter 4. Market Indicators

Chapter 5. Industry Outlook

  • 5.1. Market Dynamics
    • 5.1.1. Trends
    • 5.1.2. Drivers
    • 5.1.3. Restraints/challenges
    • 5.1.4. Impact analysis of drivers/restraints
  • 5.2. Impact of COVID-19
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Bargaining power of buyers
    • 5.3.2. Bargaining power of suppliers
    • 5.3.3. Threat of new entrants
    • 5.3.4. Intensity of rivalry
    • 5.3.5. Threat of substitutes

Chapter 6. Global Market

  • 6.1. Overview
  • 6.2. Market Volume, by Product (2017-2030)
  • 6.3. Market Revenue, by Product (2017-2030)
  • 6.4. Market Volume, by Age Category (2017-2030)
  • 6.5. Market Revenue, by Age Category (2017-2030)
  • 6.6. Market Volume, by Flow Type (2017-2030)
  • 6.7. Market Revenue, by Flow Type (2017-2030)
  • 6.8. Market Volume, by Application (2017-2030)
  • 6.9. Market Revenue, by Application (2017-2030)
  • 6.10. Market Volume, by End User (2017-2030)
  • 6.11. Market Revenue, by End User (2017-2030)
  • 6.12. Market Volume, by Region (2017-2030)
  • 6.13. Market Revenue, by Region (2017-2030)

Chapter 7. North America Market

  • 7.1. Overview
  • 7.2. Market Volume, by Product (2017-2030)
  • 7.3. Market Revenue, by Product (2017-2030)
  • 7.4. Market Volume, by Age Category (2017-2030)
  • 7.5. Market Revenue, by Age Category (2017-2030)
  • 7.6. Market Volume, by Flow Type (2017-2030)
  • 7.7. Market Revenue, by Flow Type (2017-2030)
  • 7.8. Market Volume, by Application (2017-2030)
  • 7.9. Market Revenue, by Application (2017-2030)
  • 7.10. Market Volume, by End User (2017-2030)
  • 7.11. Market Revenue, by End User (2017-2030)
  • 7.12. Market Volume, by Country (2017-2030)
  • 7.13. Market Revenue, by Country (2017-2030)

Chapter 8. Europe Market

  • 8.1. Overview
  • 8.2. Market Volume, by Product (2017-2030)
  • 8.3. Market Revenue, by Product (2017-2030)
  • 8.4. Market Volume, by Age Category (2017-2030)
  • 8.5. Market Revenue, by Age Category (2017-2030)
  • 8.6. Market Volume, by Flow Type (2017-2030)
  • 8.7. Market Revenue, by Flow Type (2017-2030)
  • 8.8. Market Volume, by Application (2017-2030)
  • 8.9. Market Revenue, by Application (2017-2030)
  • 8.10. Market Volume, by End User (2017-2030)
  • 8.11. Market Revenue, by End User (2017-2030)
  • 8.12. Market Volume, by Country (2017-2030)
  • 8.13. Market Revenue, by Country (2017-2030)

Chapter 9. APAC Market

  • 9.1. Overview
  • 9.2. Market Volume, by Product (2017-2030)
  • 9.3. Market Revenue, by Product (2017-2030)
  • 9.4. Market Volume, by Age Category (2017-2030)
  • 9.5. Market Revenue, by Age Category (2017-2030)
  • 9.6. Market Volume, by Flow Type (2017-2030)
  • 9.7. Market Revenue, by Flow Type (2017-2030)
  • 9.8. Market Volume, by Application (2017-2030)
  • 9.9. Market Revenue, by Application (2017-2030)
  • 9.10. Market Volume, by End User (2017-2030)
  • 9.11. Market Revenue, by End User (2017-2030)
  • 9.12. Market Volume, by Country (2017-2030)
  • 9.13. Market Revenue, by Country (2017-2030)

Chapter 10. LATAM Market

  • 10.1. Overview
  • 10.2. Market Volume, by Product (2017-2030)
  • 10.3. Market Revenue, by Product (2017-2030)
  • 10.4. Market Volume, by Age Category (2017-2030)
  • 10.5. Market Revenue, by Age Category (2017-2030)
  • 10.6. Market Volume, by Flow Type (2017-2030)
  • 10.7. Market Revenue, by Flow Type (2017-2030)
  • 10.8. Market Volume, by Application (2017-2030)
  • 10.9. Market Revenue, by Application (2017-2030)
  • 10.10. Market Volume, by End User (2017-2030)
  • 10.11. Market Revenue, by End User (2017-2030)
  • 10.12. Market Volume, by Country (2017-2030)
  • 10.13. Market Revenue, by Country (2017-2030)

Chapter 11. MEA Market

  • 11.1. Overview
  • 11.2. Market Volume, by Product (2017-2030)
  • 11.3. Market Revenue, by Product (2017-2030)
  • 11.4. Market Volume, by Age Category (2017-2030)
  • 11.5. Market Revenue, by Age Category (2017-2030)
  • 11.6. Market Volume, by Flow Type (2017-2030)
  • 11.7. Market Revenue, by Flow Type (2017-2030)
  • 11.8. Market Volume, by Application (2017-2030)
  • 11.9. Market Revenue, by Application (2017-2030)
  • 11.10. Market Volume, by End User (2017-2030)
  • 11.11. Market Revenue, by End User (2017-2030)
  • 11.12. Market Volume, by Country (2017-2030)
  • 11.13. Market Revenue, by Country (2017-2030)

Chapter 12. U.S. Market

  • 12.1. Overview
  • 12.2. Market Volume, by Product (2017-2030)
  • 12.3. Market Revenue, by Product (2017-2030)
  • 12.4. Market Volume, by Age Category (2017-2030)
  • 12.5. Market Revenue, by Age Category (2017-2030)
  • 12.6. Market Volume, by Flow Type (2017-2030)
  • 12.7. Market Revenue, by Flow Type (2017-2030)
  • 12.8. Market Volume, by Application (2017-2030)
  • 12.9. Market Revenue, by Application (2017-2030)
  • 12.10. Market Volume, by End User (2017-2030)
  • 12.11. Market Revenue, by End User (2017-2030)

Chapter 13. Canada Market

  • 13.1. Overview
  • 13.2. Market Volume, by Product (2017-2030)
  • 13.3. Market Revenue, by Product (2017-2030)
  • 13.4. Market Volume, by Age Category (2017-2030)
  • 13.5. Market Revenue, by Age Category (2017-2030)
  • 13.6. Market Volume, by Flow Type (2017-2030)
  • 13.7. Market Revenue, by Flow Type (2017-2030)
  • 13.8. Market Volume, by Application (2017-2030)
  • 13.9. Market Revenue, by Application (2017-2030)
  • 13.10. Market Volume, by End User (2017-2030)
  • 13.11. Market Revenue, by End User (2017-2030)

Chapter 14. Germany Market

  • 14.1. Overview
  • 14.2. Market Volume, by Product (2017-2030)
  • 14.3. Market Revenue, by Product (2017-2030)
  • 14.4. Market Volume, by Age Category (2017-2030)
  • 14.5. Market Revenue, by Age Category (2017-2030)
  • 14.6. Market Volume, by Flow Type (2017-2030)
  • 14.7. Market Revenue, by Flow Type (2017-2030)
  • 14.8. Market Volume, by Application (2017-2030)
  • 14.9. Market Revenue, by Application (2017-2030)
  • 14.10. Market Volume, by End User (2017-2030)
  • 14.11. Market Revenue, by End User (2017-2030)

Chapter 15. France Market

  • 15.1. Overview
  • 15.2. Market Volume, by Product (2017-2030)
  • 15.3. Market Revenue, by Product (2017-2030)
  • 15.4. Market Volume, by Age Category (2017-2030)
  • 15.5. Market Revenue, by Age Category (2017-2030)
  • 15.6. Market Volume, by Flow Type (2017-2030)
  • 15.7. Market Revenue, by Flow Type (2017-2030)
  • 15.8. Market Volume, by Application (2017-2030)
  • 15.9. Market Revenue, by Application (2017-2030)
  • 15.10. Market Volume, by End User (2017-2030)
  • 15.11. Market Revenue, by End User (2017-2030)

Chapter 16. U.K. Market

  • 16.1. Overview
  • 16.2. Market Volume, by Product (2017-2030)
  • 16.3. Market Revenue, by Product (2017-2030)
  • 16.4. Market Volume, by Age Category (2017-2030)
  • 16.5. Market Revenue, by Age Category (2017-2030)
  • 16.6. Market Volume, by Flow Type (2017-2030)
  • 16.7. Market Revenue, by Flow Type (2017-2030)
  • 16.8. Market Volume, by Application (2017-2030)
  • 16.9. Market Revenue, by Application (2017-2030)
  • 16.10. Market Volume, by End User (2017-2030)
  • 16.11. Market Revenue, by End User (2017-2030)

Chapter 17. Italy Market

  • 17.1. Overview
  • 17.2. Market Volume, by Product (2017-2030)
  • 17.3. Market Revenue, by Product (2017-2030)
  • 17.4. Market Volume, by Age Category (2017-2030)
  • 17.5. Market Revenue, by Age Category (2017-2030)
  • 17.6. Market Volume, by Flow Type (2017-2030)
  • 17.7. Market Revenue, by Flow Type (2017-2030)
  • 17.8. Market Volume, by Application (2017-2030)
  • 17.9. Market Revenue, by Application (2017-2030)
  • 17.10. Market Volume, by End User (2017-2030)
  • 17.11. Market Revenue, by End User (2017-2030)

Chapter 18. Spain Market

  • 18.1. Overview
  • 18.2. Market Volume, by Product (2017-2030)
  • 18.3. Market Revenue, by Product (2017-2030)
  • 18.4. Market Volume, by Age Category (2017-2030)
  • 18.5. Market Revenue, by Age Category (2017-2030)
  • 18.6. Market Volume, by Flow Type (2017-2030)
  • 18.7. Market Revenue, by Flow Type (2017-2030)
  • 18.8. Market Volume, by Application (2017-2030)
  • 18.9. Market Revenue, by Application (2017-2030)
  • 18.10. Market Volume, by End User (2017-2030)
  • 18.11. Market Revenue, by End User (2017-2030)

Chapter 19. Japan Market

  • 19.1. Overview
  • 19.2. Market Volume, by Product (2017-2030)
  • 19.3. Market Revenue, by Product (2017-2030)
  • 19.4. Market Volume, by Age Category (2017-2030)
  • 19.5. Market Revenue, by Age Category (2017-2030)
  • 19.6. Market Volume, by Flow Type (2017-2030)
  • 19.7. Market Revenue, by Flow Type (2017-2030)
  • 19.8. Market Volume, by Application (2017-2030)
  • 19.9. Market Revenue, by Application (2017-2030)
  • 19.10. Market Volume, by End User (2017-2030)
  • 19.11. Market Revenue, by End User (2017-2030)

Chapter 20. China Market

  • 20.1. Overview
  • 20.2. Market Volume, by Product (2017-2030)
  • 20.3. Market Revenue, by Product (2017-2030)
  • 20.4. Market Volume, by Age Category (2017-2030)
  • 20.5. Market Revenue, by Age Category (2017-2030)
  • 20.6. Market Volume, by Flow Type (2017-2030)
  • 20.7. Market Revenue, by Flow Type (2017-2030)
  • 20.8. Market Volume, by Application (2017-2030)
  • 20.9. Market Revenue, by Application (2017-2030)
  • 20.10. Market Volume, by End User (2017-2030)
  • 20.11. Market Revenue, by End User (2017-2030)

Chapter 21. India Market

  • 21.1. Overview
  • 21.2. Market Volume, by Product (2017-2030)
  • 21.3. Market Revenue, by Product (2017-2030)
  • 21.4. Market Volume, by Age Category (2017-2030)
  • 21.5. Market Revenue, by Age Category (2017-2030)
  • 21.6. Market Volume, by Flow Type (2017-2030)
  • 21.7. Market Revenue, by Flow Type (2017-2030)
  • 21.8. Market Volume, by Application (2017-2030)
  • 21.9. Market Revenue, by Application (2017-2030)
  • 21.10. Market Volume, by End User (2017-2030)
  • 21.11. Market Revenue, by End User (2017-2030)

Chapter 22. Australia Market

  • 22.1. Overview
  • 22.2. Market Volume, by Product (2017-2030)
  • 22.3. Market Revenue, by Product (2017-2030)
  • 22.4. Market Volume, by Age Category (2017-2030)
  • 22.5. Market Revenue, by Age Category (2017-2030)
  • 22.6. Market Volume, by Flow Type (2017-2030)
  • 22.7. Market Revenue, by Flow Type (2017-2030)
  • 22.8. Market Volume, by Application (2017-2030)
  • 22.9. Market Revenue, by Application (2017-2030)
  • 22.10. Market Volume, by End User (2017-2030)
  • 22.11. Market Revenue, by End User (2017-2030)

Chapter 23. South Korea Market

  • 23.1. Overview
  • 23.2. Market Volume, by Product (2017-2030)
  • 23.3. Market Revenue, by Product (2017-2030)
  • 23.4. Market Volume, by Age Category (2017-2030)
  • 23.5. Market Revenue, by Age Category (2017-2030)
  • 23.6. Market Volume, by Flow Type (2017-2030)
  • 23.7. Market Revenue, by Flow Type (2017-2030)
  • 23.8. Market Volume, by Application (2017-2030)
  • 23.9. Market Revenue, by Application (2017-2030)
  • 23.10. Market Volume, by End User (2017-2030)
  • 23.11. Market Revenue, by End User (2017-2030)

Chapter 24. Brazil Market

  • 24.1. Overview
  • 24.2. Market Volume, by Product (2017-2030)
  • 24.3. Market Revenue, by Product (2017-2030)
  • 24.4. Market Volume, by Age Category (2017-2030)
  • 24.5. Market Revenue, by Age Category (2017-2030)
  • 24.6. Market Volume, by Flow Type (2017-2030)
  • 24.7. Market Revenue, by Flow Type (2017-2030)
  • 24.8. Market Volume, by Application (2017-2030)
  • 24.9. Market Revenue, by Application (2017-2030)
  • 24.10. Market Volume, by End User (2017-2030)
  • 24.11. Market Revenue, by End User (2017-2030)

Chapter 25. Mexico Market

  • 25.1. Overview
  • 25.2. Market Volume, by Product (2017-2030)
  • 25.3. Market Revenue, by Product (2017-2030)
  • 25.4. Market Volume, by Age Category (2017-2030)
  • 25.5. Market Revenue, by Age Category (2017-2030)
  • 25.6. Market Volume, by Flow Type (2017-2030)
  • 25.7. Market Revenue, by Flow Type (2017-2030)
  • 25.8. Market Volume, by Application (2017-2030)
  • 25.9. Market Revenue, by Application (2017-2030)
  • 25.10. Market Volume, by End User (2017-2030)
  • 25.11. Market Revenue, by End User (2017-2030)

Chapter 26. Saudi Arabia Market

  • 26.1. Overview
  • 26.2. Market Volume, by Product (2017-2030)
  • 26.3. Market Revenue, by Product (2017-2030)
  • 26.4. Market Volume, by Age Category (2017-2030)
  • 26.5. Market Revenue, by Age Category (2017-2030)
  • 26.6. Market Volume, by Flow Type (2017-2030)
  • 26.7. Market Revenue, by Flow Type (2017-2030)
  • 26.8. Market Volume, by Application (2017-2030)
  • 26.9. Market Revenue, by Application (2017-2030)
  • 26.10. Market Volume, by End User (2017-2030)
  • 26.11. Market Revenue, by End User (2017-2030)

Chapter 27. South Africa Market

  • 27.1. Overview
  • 27.2. Market Volume, by Product (2017-2030)
  • 27.3. Market Revenue, by Product (2017-2030)
  • 27.4. Market Volume, by Age Category (2017-2030)
  • 27.5. Market Revenue, by Age Category (2017-2030)
  • 27.6. Market Volume, by Flow Type (2017-2030)
  • 27.7. Market Revenue, by Flow Type (2017-2030)
  • 27.8. Market Volume, by Application (2017-2030)
  • 27.9. Market Revenue, by Application (2017-2030)
  • 27.10. Market Volume, by End User (2017-2030)
  • 27.11. Market Revenue, by End User (2017-2030)

Chapter 28. U.A.E. Market

  • 28.1. Overview
  • 28.2. Market Volume, by Product (2017-2030)
  • 28.3. Market Revenue, by Product (2017-2030)
  • 28.4. Market Volume, by Age Category (2017-2030)
  • 28.5. Market Revenue, by Age Category (2017-2030)
  • 28.6. Market Volume, by Flow Type (2017-2030)
  • 28.7. Market Revenue, by Flow Type (2017-2030)
  • 28.8. Market Volume, by Application (2017-2030)
  • 28.9. Market Revenue, by Application (2017-2030)
  • 28.10. Market Volume, by End User (2017-2030)
  • 28.11. Market Revenue, by End User (2017-2030)

Chapter 29. Competitive Landscape

  • 29.1. List of Market Players and their Offerings
  • 29.2. Competitive Benchmarking of Key Players
  • 29.3. Product Benchmarking of Key Players
  • 29.4. Recent Strategic Developments

Chapter 30. Company Profiles

  • 30.1. Abbott Laboratories
    • 30.1.1. Business overview
    • 30.1.2. Product and service offerings
    • 30.1.3. Key financial summary
  • 30.2. Danone S.A.
    • 30.2.1. Business overview
    • 30.2.2. Product and service offerings
    • 30.2.3. Key financial summary
  • 30.3. Fresenius Kabi AG
    • 30.3.1. Business overview
    • 30.3.2. Product and service offerings
    • 30.3.3. Key financial summary
  • 30.4. Nestle S.A.
    • 30.4.1. Business overview
    • 30.4.2. Product and service offerings
    • 30.4.3. Key financial summary
  • 30.5. Victus Inc.
    • 30.5.1. Business overview
    • 30.5.2. Product and service offerings
    • 30.5.3. Key financial summary
  • 30.6. Primus Pharmaceuticals Inc.
    • 30.6.1. Business overview
    • 30.6.2. Product and service offerings
    • 30.6.3. Key financial summary
  • 30.7. Meiji Holdings Company Ltd.
    • 30.7.1. Business overview
    • 30.7.2. Product and service offerings
    • 30.7.3. Key financial summary

Chapter 31. Appendix

  • 31.1. Abbreviations
  • 31.2. Sources and References
  • 31.3. Related Reports
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제